Dare Bioscience Stock Technical Analysis
| DARE Stock | USD 1.69 0.01 0.60% |
As of the 9th of February, Dare Bioscience shows the Variance of 18.04, mean deviation of 3.06, and Standard Deviation of 4.25. Dare Bioscience technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Dare Bioscience information ratio, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Dare Bioscience is priced favorably, providing market reflects its regular price of 1.69 per share. Please also check Dare Bioscience jensen alpha, which is currently at (0.22) to verify the company can sustain itself at a future point.
Dare Bioscience Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Dare, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to DareDare Bioscience's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Dare Bioscience Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 10.75 | Strong Buy | 4 | Odds |
Most Dare analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Dare stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Dare Bioscience, talking to its executives and customers, or listening to Dare conference calls.
Will Health Care Equipment & Supplies sector continue expanding? Could Dare diversify its offerings? Factors like these will boost the valuation of Dare Bioscience. Projected growth potential of Dare fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Dare Bioscience data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.83) | Revenue Per Share | Quarterly Revenue Growth (0.95) | Return On Assets | Return On Equity |
Understanding Dare Bioscience requires distinguishing between market price and book value, where the latter reflects Dare's accounting equity. The concept of intrinsic value - what Dare Bioscience's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Dare Bioscience's price substantially above or below its fundamental value.
It's important to distinguish between Dare Bioscience's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Dare Bioscience should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Dare Bioscience's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Dare Bioscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Dare Bioscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Dare Bioscience.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in Dare Bioscience on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding Dare Bioscience or generate 0.0% return on investment in Dare Bioscience over 90 days. Dare Bioscience is related to or competes with FibroBiologics Common, Citius Pharmaceuticals, Ainos, Athira Pharma, Aspire BioPharma, Aditxt, and Palisade Bio. Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing ... More
Dare Bioscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Dare Bioscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Dare Bioscience upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 26.52 | |||
| Value At Risk | (6.98) | |||
| Potential Upside | 6.55 |
Dare Bioscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dare Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Dare Bioscience's standard deviation. In reality, there are many statistical measures that can use Dare Bioscience historical prices to predict the future Dare Bioscience's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.54) | |||
| Treynor Ratio | (0.09) |
Dare Bioscience February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.08) | |||
| Mean Deviation | 3.06 | |||
| Coefficient Of Variation | (3,998) | |||
| Standard Deviation | 4.25 | |||
| Variance | 18.04 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.54) | |||
| Treynor Ratio | (0.09) | |||
| Maximum Drawdown | 26.52 | |||
| Value At Risk | (6.98) | |||
| Potential Upside | 6.55 | |||
| Skewness | 1.02 | |||
| Kurtosis | 4.3 |
Dare Bioscience Backtested Returns
Dare Bioscience secures Sharpe Ratio (or Efficiency) of -0.0326, which denotes the company had a -0.0326 % return per unit of risk over the last 3 months. Dare Bioscience exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Dare Bioscience's Variance of 18.04, mean deviation of 3.06, and Standard Deviation of 4.25 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.26, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Dare Bioscience will likely underperform. At this point, Dare Bioscience has a negative expected return of -0.14%. Please make sure to confirm Dare Bioscience's kurtosis, and the relationship between the value at risk and rate of daily change , to decide if Dare Bioscience performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.65 |
Very good reverse predictability
Dare Bioscience has very good reverse predictability. Overlapping area represents the amount of predictability between Dare Bioscience time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Dare Bioscience price movement. The serial correlation of -0.65 indicates that roughly 65.0% of current Dare Bioscience price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.65 | |
| Spearman Rank Test | -0.18 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Dare Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Dare Bioscience Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Dare Bioscience volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Dare Bioscience Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Dare Bioscience on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Dare Bioscience based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Dare Bioscience price pattern first instead of the macroeconomic environment surrounding Dare Bioscience. By analyzing Dare Bioscience's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Dare Bioscience's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Dare Bioscience specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Interest Debt Per Share | 0.19 | 0.15 | 0.18 | 0.17 | Revenue Per Share | 0.39 | 0.001151 | 0.001324 | 0.001258 |
Dare Bioscience February 9, 2026 Technical Indicators
Most technical analysis of Dare help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Dare from various momentum indicators to cycle indicators. When you analyze Dare charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.08) | |||
| Mean Deviation | 3.06 | |||
| Coefficient Of Variation | (3,998) | |||
| Standard Deviation | 4.25 | |||
| Variance | 18.04 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.54) | |||
| Treynor Ratio | (0.09) | |||
| Maximum Drawdown | 26.52 | |||
| Value At Risk | (6.98) | |||
| Potential Upside | 6.55 | |||
| Skewness | 1.02 | |||
| Kurtosis | 4.3 |
Dare Bioscience February 9, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Dare stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.03 | ||
| Daily Balance Of Power | 0.17 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 1.72 | ||
| Day Typical Price | 1.71 | ||
| Price Action Indicator | (0.03) | ||
| Market Facilitation Index | 0.06 |
Complementary Tools for Dare Stock analysis
When running Dare Bioscience's price analysis, check to measure Dare Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dare Bioscience is operating at the current time. Most of Dare Bioscience's value examination focuses on studying past and present price action to predict the probability of Dare Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dare Bioscience's price. Additionally, you may evaluate how the addition of Dare Bioscience to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |